Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 51 results for "kiran mazumdar shaw"

Ban open burning of all wastes, says Kiran Mazumdar-Shaw

Vehicle emission and burning of toxic waste are the key factors fuelling air pollution, says Mazumdar-Shaw, Chairperson and Managing Director of biotechnology firm, Biocon. DNA, 15 hours ago

70 images for kiran mazumdar shaw, 2 weeks ago
Business Standard, 2 weeks ago
Financial Express, 2 weeks ago
DealStreetAsia, 2 weeks ago
DNA, 1 week ago
Deccan Chronicle, 2 months ago
India Blooms, 2 months ago, 2 months ago
Financial Express, 2 weeks ago
Financial Express, 2 months ago

No breakdown in corporate governance at Infosys: Mazumdar-Shaw

Infosys board member and Biocon Chairperson Kiran Mazumdar-Shaw today asserted that there has been no breach in corporate governance at the IT bellwether, but said there may be some "judgement calls" on which the board differed with the promoters.
 DNA1 week ago Infosys: Kiran Mazumdar-Shaw defends Vishal Sikka, board decisions  First Post.com1 week ago Newsmaker of the Week: THE SAMURAI  The Financial Chronicle3 days ago I have not withdrawn governance concerns: Narayana Murthy  Deccan Herald6 days ago
Money Control

Biocon well-poised to be a frontrunner in biosimilars: MD

Attributing the strong show in Q3FY17 to robust performance in biologics, Biocon Chairperson and MD Kiran Mazumdar-Shaw told CNBC-TV18 that Biocon is well poised to be front-runner in biosimilars. The acceptance of biosimilar Trastuzumab by the USFDA is a ...
 Money Control3 weeks ago Demonetisation has impacted Indian sales, not exports: Biocon  Money Control2 months ago Demonetisation to help leapfrog to digital economy: Biocon CMD  Money Control2 months ago

The Times of India shared a link.

Budget “safe and balanced” but could have been bolder: Kiran Mazumdar Shaw
 Current News India2 weeks ago Budget "safe and balanced" but could have been bolder  DNA2 weeks ago Budget: A delicate balancing act with rural push  Rediff.com2 weeks ago Union Budget 2017 reactions: What experts have to say  catchnews.com2 weeks ago

India Economic Survey 2017: Experts feel that this isn't the time to reign in fiscal deficit

On the point of sticking to fiscal deficit target, Kiran Mazumdar Shaw, CMD of Biocon said that it is not the time to reign in fiscal deficit and investments should be done in infrastructure and digitisation.
 Money Control2 weeks ago

Kiran Mazumdar-Shaw: e-health push can build 'Swastha Bharat'

In 2017 govt should push for increased adoption of technology to transform public health care system
 Business Standard1 month ago Why 'Swastha Bharat' needs the e-health push  Rediff.com1 month ago

Kiran Mazumdar-Shaw silences her Twitter trolls with a 78% stock rally

It was the best return among shares of generic drugmakers worldwide
 Business Standard2 months ago Kiran Mazumdar-Shaw silences Twitter trolls with a 78% Biocon stock rally  Business Standard2 months ago

At Infosys, issue is difference in perceptions: Mazumdar Shaw

This time it is Infosys that is caught up in the net of the 'bitter boardroom battle' as the rift between the founders and the board is out in the open. But, Kiran Mazumdar Shaw, Independent Director at Infosys says, “these are not governance issues, these ...
 Money Control1 week ago 'All that happened about a year ago': Mazumdar-Shaw on Infy 'rift'  Rediff.com1 week ago Cracks in Infosys widen, Bala demands Seshasayee’s head  The Financial Chronicle1 week ago Infy founders, board clash over governance, compensation  Deccan Herald1 week ago

Once upon a time in India Inc...

The list of corporations publishing biographies has lengthened steadily as companies have realised the effectiveness of story telling as a brand building tool. Kanika Datta investigates the rising trend. Illustration: Dominic Xavier/ The dismantling of the licence raj from 1991 onwards provided corporate India with a new-found freedom to grow in any way it chose. Now, well into the 21st century, many corporations and promoters have achieved critical mass. In the process, they ...
 Rediff.com13 hours ago

Biocon chief sees anti-cancer biosimilar launch in FY19

Biocon Thursday announced the US Food and Drug Administration has accepted Mylan’s Biologics License Application (BLA) for biosimilar chemotherapy drug Pegfilgrastim for review. Sharing details on the development with CNBC-TV18 Biocon Chairperson and ...
 Money Control3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less